3 ML somatropin 10 MG/ML Pen Injector [Norditropin] — RxCUI 849851
RxNorm drug concept · Semantic branded drug
RxCUI 849851
Semantic branded drug · SBD
● Current RxNorm concept 4 FDA products
8 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI849851
Official name3 ML somatropin 10 MG/ML Pen Injector [Norditropin]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asNorditropin 30 MG per 3 ML Pen Injector; Norditropin 30 MG in 3 ML Pen Injector
FDA products mapped4
Package NDCs mapped8
Reported Medicaid activity (SDUD)91,469 prescriptions · 49 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Somatropin: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Somatropin is a lab-made version of the growth hormone your body naturally produces. Your doctor has likely prescribed it because your body — or your child's body — isn't making en...
- What exactly is somatropin and why has my doctor prescribed it?
- You'll inject it just under the skin — not into a vein or deep muscle. Common spots are the belly, thigh, upper arm, or buttock. The most important habit to get into is rotating yo...
- How do I give the injection, and does it hurt?
🕸️ Concept Web — How 3 ML somatropin 10 MG/ML Pen Injector [Norditrop... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
3 ML somatropin 10 MG/ML Pen Injector [Norditropin]
RxCUI 849851 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Somatropin
61148IN
-
Somatropin
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Norditropin
202829BN
-
Norditropin
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Somatropin Pen Injector
1735493SCDF -
Somatropin Injectable Product
1159952SCDG -
Somatropin Pen Injector [Norditropin]
1736132SBDF -
Norditropin Injectable Product
1185122SBDG -
Pen Injector
1649571DF -
Injectable Product
1151126DFG
-
Somatropin Pen Injector
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
3 ML somatropin 10 MG/ML Pen Injector
849850SCD -
Somatropin 10 MG/ML
331546SCDC -
Somatropin 10 MG/ML [Norditropin]
727646SBDC
-
3 ML somatropin 10 MG/ML Pen Injector
Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
3 ML somatropin 10 MG/ML Pen Injector
SCD · 849850 -
Somatropin 10 MG/ML
SCDC · 331546 -
Somatropin Pen Injector
SCDF · 1735493 -
Somatropin Injectable Product
SCDG · 1159952
Brand-Name Concepts
-
Somatropin 10 MG/ML [Norditropin]
SBDC · 727646 -
Somatropin Pen Injector [Norditropin]
SBDF · 1736132 -
Norditropin Injectable Product
SBDG · 1185122 -
Norditropin
BN · 202829
📦 FDA Products & Package NDCs
4 products · 8 package NDCs
8 package NDCs map to RxCUI 849851 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00169-7703-21 | 1 SYRINGE in 1 CARTON (0169-7703-21) / 3 mL in 1 SYRINGE | Norditropin | Novo Nordisk | 2015-01-23 |
| 00169-7703-92 | 1 SYRINGE in 1 CARTON (0169-7703-92) / 3 mL in 1 SYRINGE | Norditropin | Novo Nordisk | 2015-01-23 |
| 00169-7704-21 | 1 SYRINGE, PLASTIC in 1 CARTON (0169-7704-21) / 1.5 mL in 1... | Norditropin | Novo Nordisk | 2010-03-01 |
| 00169-7704-92 | 1 SYRINGE, PLASTIC in 1 CARTON (0169-7704-92) / 1.5 mL in 1... | Norditropin | Novo Nordisk | 2010-03-01 |
| 00169-7705-21 | 1 SYRINGE, PLASTIC in 1 CARTON (0169-7705-21) / 1.5 mL in 1... | Norditropin | Novo Nordisk | 2010-03-01 |
| 00169-7705-92 | 1 SYRINGE, PLASTIC in 1 CARTON (0169-7705-92) / 1.5 mL in 1... | Norditropin | Novo Nordisk | 2010-03-01 |
| 00169-7708-21 | 1 SYRINGE, PLASTIC in 1 CARTON (0169-7708-21) / 1.5 mL in 1... | Norditropin | Novo Nordisk | 2010-03-01 |
| 00169-7708-92 | 1 SYRINGE, PLASTIC in 1 CARTON (0169-7708-92) / 1.5 mL in 1... | Norditropin | Novo Nordisk | 2010-03-01 |
Observed labelers:
Novo Nordisk (8)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.